458 results on '"Bláha, M."'
Search Results
102. 18 Clinical importance of statin monitoring after extracorporeal LDL-cholesterol elimination
103. 36 Report of World Apheresis Association registry data until June 2010
104. 19 Extracorporeal immunoglobulin elimination in the long-term treatment of severe myasthenia gravis
105. Ex vivo expansion CD34+/AC133+ - selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy.
106. Abstract: P849 HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CZ (A 15YEAR EXPERIENCE WITH EXTRACORPOREAL LDL-ELIMINATION)
107. CHANGES OF LABORATORY PARAMETERS DURING LONG-TERM EXTRACORPOREAL LDL-CHOLESTEROL ELIMINATION
108. DETERMINATION OF STATINS IN BIOLOGICAL MATERIALS
109. OUTCOME COMPARISON TO TAKE ADVANTAGE OF MODIFIED PLATELETS AGGREGATION AND PFA-100 ANALYSIS TO RATIONALIZE THERAPEUTIC LDL-APHERESIS PROCEDURE
110. INTERVENTION IMPROVES ATHEROGENIC LOW-GRADE INFLAMMATION MARKED BY MACROPHAGE CHEMOATTRACTANT PROTEIN-1 (MCP-1) IN END STAGE RENAL DISEASE (ESRD) PATIENTS
111. PO23-766 EZETIMIBE, STATIN AND LDL-APHERESIS IN COMBINED TREATMENT OF SEVERE HYPERCHOLESTEROLEMIA
112. The role of erythrocytapheresis in secondary erythrocytosis therapy.
113. T07-P-002 LDL-lowering immunoapheresis is well tolerated and safe procedure in familial hyperlipoproteinaemia
114. T07-P-001 Haemostasis and LDL-apheresis in familial hypercholesterolaemia
115. W16-P-008 Assessment of absorber efficacy during LDL-apheresis
116. W01.132 Relation of carotid intima-media thickness and endothelial dysfunction during long-term aggressive lipid lowering with LDL apheresis
117. Position of lipoprotein apheresis in present | Postavení lipoproteinové aferézy v současnosti
118. LDL-apheresis in the treatment familial hypercholesterolemia | LDL-aferéza v léčbě familiárních hyperlipoproteinemii
119. Therapeutic plasmapheresis in the therapy of neurological diseases - One center experience | Terapeutická plazmaferéza v lébě neurologických onemonění - Vlastní zkušenosti
120. Separation of granulocytes on the Travenol CS-3000 separator | Výtézky granulocytů na separátoru Travenol, CS-3000
121. Therapy of percentual hearing loss by rheohemapheresis - First experience | Léčba percepční ztráty sluchu reohemaferézou - První zkušenosti
122. Bleeding time in incisions in patients with thrombocyte transfusion | Vysetrení krvácivosti v rezu u nemocných s prevody trombocytů
123. Changes in the activity of thrombocytes by smoking
124. [Surgical approach to the sphenoid sinus in microsurgery of hypophyseal tumors]
125. Granulocyte transfusion therapy | Lécba transfúzemi granulocytů
126. Changes in platelet function in patients with arterial hypertension | Změny destickových funkcí u nemocných s arteriální hypertenzí
127. Use of the isoradial chamber in the preparation of thrombocyte concentrates using the Travenol CS-3000 separator | Vyuzití izoradiální komůrky k prípravě trombocytárních koncentrátů na separátoru Travenol CS-3000
128. Selection criteria for treatment of severe hyperlipoproteinemias with LDL apheresis | Selekcní kritéria k léc be závazných hyperlipoproteinémií metodou LDL aferéz
129. LDL apheresis - Evaluation of the results from 1000 performed procedures | LDL-aferéza - Zhodnocení výsledků 1000 provedených procedur
130. Selectins and monocyte chemotactic peptide as the markers of atherosclerosis activity
131. [Influence of haemorheopheresis in the dry form of the age related macular degeneration]
132. Selective decontamination of the digestive tract for the prevention of infection in patients with neutropenia | Selektivní dekontaminace trávicího traktu jako prevence infekcí u nemocných s neutropenií
133. Myeloid differentiation and maturation of SCF+IL-3+IL-11 expanded AC133+/CD34+ cells selected from high-risk breast cancer patients
134. Antithrombin III in various conditions in internal medicine | Antitrombin III u nekterých stavů ve vnitrním lékarství
135. Endothelium and haemostasis | Endotel v systému hemostázy Část II. Diagnostika endotelové dysfunkce a léčebné možnosti
136. A case of 'acute' Waldenström macroglobulinaemia
137. Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods | Extrakorporální eliminace LDL-cholesterolu v lécbe hypercholesterolémií: indikace a metody
138. Omentoplasty of the sternum--surgical solution in a sternal defect due to sternal osteomyelitis in a female patient with mediastinal localization of a parathyroid adenoma. Case report,Omentoplastika sterna--chirurgické resení defektu sterna pri osteomyelitide sterna u pacientky s mediastinálne ulozeným adenomem paratyreoidey. Kazuistika
139. Selection of a compatible donor using the blood platelet aggregation technic | Výběr kompatibilního dárce technikou agregace krevních desticek
140. Treatment of severely depressed hematopoiesis | Lécba tězkých útlumů krvetvorby
141. Preparation of thrombocyte concentrates in the Travenol CS-3000 separator (factors affecting the thrombocyte yield and presence of leukocytes) | Príprava trombocytárních koncentrátů separátorem Travenol CS-3000 (faktory mající vliv na výtězek trombocytů a príměs leukocytů)
142. The role of erythrocytapheresis in secondary erythrocytosis therapy
143. Methods of replacing circulating volume in plasma exchange | Metodika náhrady cévního objemu pri výměně plazmy
144. Influence of haemorheopheresis in the dry form of the age related macular degeneration | Možnost ovlivnění suché formy věkem podmǐnéně makulǎrní degenerace hemorheoferézou
145. Effects of caffeine on cerebral blood flow,Vliv kofeinu na průtok krve mozkem
146. Circulation of progenitor cells after intensive chemotherapy followed by combination G-CSF and EPO in breast carcinoma
147. Phagocytic activity of granulocytes in patients with malignant lymphomas | Fagocytární aktivita granulocytů u nemocných se zhoubnými lymfomy
148. Changes in hemostasis in leukocyte donors | Změny hemostázy u dárců leukocytů
149. Parametric monitoring of the quality of total mesorectal excision and surgical treatment of rectal carcinoma results of a multicenter study,Parametrické sledování kvality totální mezorektální excize a chirurgické léčby karcinomu rekta výsledky multicentrické studie
150. Platelet transfusion therapy | Lécba prevody krevních desticek
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.